P110α-mediated constitutive PI3K signaling limits the efficacy of p110δ-selective inhibition in mantle cell lymphoma, particularly with multiple relapse

Phosphoinositide-3 kinase (PI3K) pathway activation contributes to mantle cell lymphoma (MCL) pathogenesis, but early-phase studies of the PI3K p110δ inhibitor GS-1101 have reported inferior responses in MCL compared with other non-Hodgkin lymphomas. Because the relative importance of the class IA P...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Iyengar, Sunil, Clear, Andrew, Bödör, Csaba, Maharaj, Lenushka, Lee, Abigail, Calaminici, Maria, Matthews, Janet, Iqbal, Sameena, Auer, Rebecca, Gribben, John, Joel, Simon
פורמט: Artigo
שפה:Inglês
יצא לאור: American Society of Hematology 2013
נושאים:
Lymphoid Neoplasia
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC3606064/
https://ncbi.nlm.nih.gov/pubmed/23341541
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2012-10-460832
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים